Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving ...
Scientists at Stanford University have discovered that DRT3, a unique defense system found in bacteria, creates DNA to ...
Following Flagship's origination of generative protein and mRNA platforms, Serif is pioneering Modified DNA medicines to program the foundational information layer of biology Serif to present data at ...
Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that an abstract highlighting preclinical data from SG293, ...
With a few chemical tweaks and some dutiful protein partners, a new biotech from Flagship Pioneering thinks it has cracked ...
The ability to precisely edit the genomes of bacteria has long been a goal of microbiologists. Such technology would enable ...
April 27 DNA Day” Youth Forum was held in Baku, gathering scientists, geneticists, and young researchers to mark DNA Day and ...
UGC Chairman Professor Dr Mamun Ahmed said biotechnology curricula are still overly theoretical and not aligned with industry needs.
The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger ...
Flagship Pioneering launched Serif Biomedicines to create modified DNA drugs, taking the best features of mRNA and gene ...
MarketBeat on MSN
3 Biotech Stocks That Could Benefit from the Patent Cliff
Biotechnology stocks have seen a spike in merger and acquisition (M&A) activity. In March 2026 alone, there were 10 deals valued at approximately $31.5 billion. A key reason for this activity is the ...
A major collaboration involving nine labs, led by scientists at Gladstone Institutes, has transferred a particularly useful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results